| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | DUF4599 | 1.50e-07 | 12 | 217 | 5 | PF15371 | |
| Domain | DUF4599 | 1.50e-07 | 12 | 217 | 5 | IPR027970 | |
| Pubmed | 6.33e-11 | 6 | 224 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.33e-11 | 6 | 224 | 5 | 25930072 | |
| Pubmed | IQGAP2 MYO5A DOCK11 ADGRB3 ZMYM2 EDC4 TENM2 GATAD2B NF1 MDN1 FAM120A FAM120C SHANK1 RGPD2 SYNE1 KCNAB2 DYRK1A CCT4 CIT WDR45 MTOR N4BP2 KIAA1217 PDE4DIP BRD7 CNOT1 TP53BP1 | 1.77e-10 | 963 | 224 | 27 | 28671696 | |
| Pubmed | BCL9L SYN3 MAP1B MYO5A VPS45 ADGRB3 EDC4 TENM2 GATAD2B STIM1 NF1 KCNF1 FAM120C SHANK1 RGPD2 USP24 APBA1 KCNAB2 CCT4 LDHA CIT TRAP1 KIAA1217 PDE4DIP TENM1 MRPS9 CNOT1 TP53BP1 | 1.51e-09 | 1139 | 224 | 28 | 36417873 | |
| Pubmed | 4.08e-07 | 24 | 224 | 5 | 32212159 | ||
| Pubmed | 1.05e-06 | 4 | 224 | 3 | 31636267 | ||
| Pubmed | USP34 GGA2 CAND2 PIEZO1 ADGRB3 KDM3B NRXN3 SUPT6H CELSR3 SETBP1 AUTS2 SETD7 IGSF1 CNOT1 NIN | 2.06e-06 | 529 | 224 | 15 | 14621295 | |
| Pubmed | SCFD2 USP34 CAND2 MAP1B IQGAP2 VPS45 BCL3 EDC4 ITPR2 NOP9 MDN1 FAM120A POMP COG4 ATF7 PIGS BAG5 CCT4 LDHA TRAP1 POLR3B MTOR TMEM209 MRPS9 TRAPPC14 CNOT1 | 2.35e-06 | 1440 | 224 | 26 | 30833792 | |
| Pubmed | IQGAP2 USP11 ZMYM2 TSPYL1 EDC4 GATAD2B CDC45 SUPT6H PKP2 PIP5K1A CLUH TRAP1 POLR3B SETD7 CNOT1 | 4.10e-06 | 560 | 224 | 15 | 35241646 | |
| Pubmed | USP34 MAP1B MYO5A USP11 EDC4 NF1 MDN1 FAM120A SUPT6H CLUH PUF60 USP24 MTOR CNOT1 CPSF3 TP53BP1 | 6.01e-06 | 653 | 224 | 16 | 22586326 | |
| Pubmed | SYN3 MAP1B IQGAP2 MYO5A VPS45 EDC4 ITPR2 NF1 FAM120A FAM120C PTPRZ1 HSDL1 SHANK1 SYNE1 KCNAB2 DYRK1A CCT4 LDHA CIT SLC25A12 KIAA1217 PDE4DIP MRPS9 CNOT1 DNPEP | 6.59e-06 | 1431 | 224 | 25 | 37142655 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYO5A CEP85L NAGLU STIM1 MDN1 IMP4 PKP2 RBMS1 PIGS BAG5 CIT MTOR PDE4DIP MRPS9 CPSF3 DNPEP NIN | 9.10e-06 | 754 | 224 | 17 | 33060197 |
| Pubmed | USP34 MYO5A CEP85L USP11 VPS45 ADGRB3 ZMYM2 RYR3 JAK1 FAM120A SMPD3 COG4 SHANK1 SYNE1 APBA1 KCNAB2 DYRK1A CIT SPRYD7 POLR3B CELSR3 PDE4DIP MRPS9 | 1.07e-05 | 1285 | 224 | 23 | 35914814 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MAP1B IQGAP2 USP11 ZMYM2 GATAD2B NOP9 MDN1 FAM120A ZBTB40 ATF7 UBR2 PUF60 DYRK1A DEPDC1 NFATC2IP SETD7 NHEJ1 TP53BP1 | 1.28e-05 | 857 | 224 | 18 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP1B DOCK11 CEP85L KDM3B EDC4 STIM1 ZCCHC14 NF1 MDN1 PKP2 DYRK1A PABIR2 MTOR N4BP2 KIAA1217 TRAPPC14 PLK4 EDRF1 | 1.37e-05 | 861 | 224 | 18 | 36931259 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | PSG11 PIEZO1 SDCCAG8 KDM3B TENM2 ZBTB40 MMP12 AFF2 MUC16 SLC39A12 DPH5 PDE4DIP TMEM209 TENM1 | 1.59e-05 | 552 | 224 | 14 | 10737800 |
| Pubmed | 1.69e-05 | 225 | 224 | 9 | 12168954 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DOCK11 USP11 ITPR2 NF1 SUPT6H IMP4 SMG9 PKP2 DYRK1A BRD7 TMEM209 TP53BP1 | 3.21e-05 | 440 | 224 | 12 | 34244565 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 CDH26 TP53INP1 MAP1B MYO5A VPS45 SDCCAG8 NDUFB8 ZNF440 FAM120A FAM120C SUPT6H TOX3 PIP5K1A ATF7 UBR2 DDR1 ATP10A DNAH1 PARP10 KIAA1217 SETBP1 AUTS2 CNOT1 | 3.73e-05 | 1489 | 224 | 24 | 28611215 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | MAP1B TSPYL1 EDC4 NOP9 FAM120A IMP4 PKP2 PIP5K1A RC3H2 PUF60 RBMS1 CCT4 MRPS9 TRAPPC14 CNOT1 | 3.83e-05 | 678 | 224 | 15 | 30209976 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.97e-05 | 313 | 224 | 10 | 38270169 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SCFD2 USP11 NDUFB8 ITPR2 CDC45 STIM1 MDN1 FAM120A ADSL IMP4 TOX3 MALSU1 HSDL1 CLUH RBMS1 SYNE1 BAG5 CCT4 TRAP1 SLC25A12 KIAA1217 BRD7 TMEM209 MRPS9 | 4.02e-05 | 1496 | 224 | 24 | 32877691 |
| Pubmed | TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV. | 4.13e-05 | 2 | 224 | 2 | 35013187 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 7720862 | ||
| Pubmed | Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis. | 4.13e-05 | 2 | 224 | 2 | 34293399 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 38288346 | ||
| Pubmed | Werner syndrome protein positively regulates XRCC4-like factor transcription. | 4.13e-05 | 2 | 224 | 2 | 24626809 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 30138330 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 27497299 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 21748792 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 21122852 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 27134178 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 17110454 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22010048 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22355127 | ||
| Pubmed | Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system. | 4.13e-05 | 2 | 224 | 2 | 16893422 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 14593101 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22308489 | ||
| Pubmed | Sphingomyelinase Disables Inactivation in Endogenous PIEZO1 Channels. | 4.13e-05 | 2 | 224 | 2 | 33027663 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 4.76e-05 | 146 | 224 | 7 | 23892456 | |
| Pubmed | Control of TurboID-dependent biotinylation intensity in proximity ligation screens. | 4.81e-05 | 100 | 224 | 6 | 36966971 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CAND2 IQGAP2 VPS45 SDCCAG8 STIM1 TMEM161A NF1 POMP CLUH NPHP1 RBMS1 PIGS WRN DYRK1A PABIR2 ACTR1B TRAP1 MTOR CNOT1 EDRF1 TP53BP1 DNPEP | 4.96e-05 | 1321 | 224 | 22 | 27173435 |
| Pubmed | BCL9L KMT2B MYO5A USP11 ZMYM2 EDC4 GATAD2B FAM120A ZBTB40 DNAH10 RBMS1 BAG5 CCT4 CIT MIDN ZZZ3 BRD7 MRPS9 AUTS2 ELF2 CNOT1 RAI2 TP53BP1 | 5.58e-05 | 1429 | 224 | 23 | 35140242 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | IL10RB CAND2 MYO5A USP11 EDC4 NDUFB8 ZCCHC14 SLC38A10 NF1 MDN1 LNX2 USP24 PHTF2 LDHA CIT ZZZ3 MTOR DNAH17 BRD7 CPSF3 DNPEP | 5.98e-05 | 1242 | 224 | 21 | 30973865 |
| Pubmed | 6.32e-05 | 105 | 224 | 6 | 9628581 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 7.51e-05 | 212 | 224 | 8 | 33853758 | |
| Pubmed | 8.50e-05 | 277 | 224 | 9 | 30745168 | ||
| Pubmed | 9.11e-05 | 14 | 224 | 3 | 9373155 | ||
| Pubmed | BCL9L KMT2B MYO5A VPS45 PIEZO1 ZMYM2 TSPYL1 EDC4 GATAD2B TMEM161A MDN1 FAM120C SUPT6H IMP4 TASOR RBMS1 SYNE1 WRN DYRK1A CCT4 CIT BRD7 EDRF1 | 1.11e-04 | 1497 | 224 | 23 | 31527615 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 36928924 | ||
| Pubmed | MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. | 1.23e-04 | 3 | 224 | 2 | 26046375 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 21861134 | ||
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 33380426 | ||
| Pubmed | PAXX promotes KU accumulation at DNA breaks and is essential for end-joining in XLF-deficient mice. | 1.23e-04 | 3 | 224 | 2 | 28051062 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 15319280 | ||
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 38134572 | ||
| Pubmed | De novo mutations in moderate or severe intellectual disability. | 1.23e-04 | 3 | 224 | 2 | 25356899 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 34044068 | ||
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 36112948 | ||
| Pubmed | Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α. | 1.23e-04 | 3 | 224 | 2 | 22765017 | |
| Pubmed | 1.39e-04 | 16 | 224 | 3 | 24126761 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 1.44e-04 | 233 | 224 | 8 | 32290105 | |
| Pubmed | Genome-wide meta-analysis identifies new susceptibility loci for migraine. | 1.53e-04 | 78 | 224 | 5 | 23793025 | |
| Pubmed | BCL9L DOCK11 TSPYL1 NF1 NYNRIN PKP2 LNX2 BAG5 TRAPPC14 CNOT1 NIN | 1.65e-04 | 446 | 224 | 11 | 24255178 | |
| Pubmed | USP34 GGA2 ATP7A IQGAP2 VPS45 KDM3B STIM1 PKP2 TASOR AFF2 WRN MUC16 CCT4 LDHA MRPS9 | 1.73e-04 | 777 | 224 | 15 | 35844135 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CDH26 MAP1B MYO5A GATAD2B KCNAB2 CCT4 LDHA ACTR1B TRAP1 SLC25A12 MTOR SETBP1 ATP1A4 | 2.16e-04 | 621 | 224 | 13 | 22794259 |
| Pubmed | VPS45 TUB STIM1 TMEM161A NF1 PKP2 PIP5K1A EFNB3 SUSD5 SPRY4 TMEM209 | 2.45e-04 | 467 | 224 | 11 | 30194290 | |
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 16733250 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 2.46e-04 | 4 | 224 | 2 | 10225957 | |
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 16108830 | ||
| Pubmed | Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response. | 2.46e-04 | 4 | 224 | 2 | 19955088 | |
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 17166833 | ||
| Pubmed | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | 2.46e-04 | 4 | 224 | 2 | 24509877 | |
| Pubmed | p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression. | 2.46e-04 | 4 | 224 | 2 | 29392777 | |
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 38216268 | ||
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 12730195 | ||
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 14585507 | ||
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 25524555 | ||
| Pubmed | 2.46e-04 | 4 | 224 | 2 | 22031597 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 2.46e-04 | 4 | 224 | 2 | 12000766 | |
| Pubmed | Human Timeless and Tipin stabilize replication forks and facilitate sister-chromatid cohesion. | 2.46e-04 | 4 | 224 | 2 | 20124417 | |
| Pubmed | 2.52e-04 | 253 | 224 | 8 | 29911972 | ||
| Pubmed | BCL9L EYA1 GATAD2B FAM120A SUPT6H TASOR RC3H2 N4BP2 BRD7 CNOT1 TP53BP1 | 2.54e-04 | 469 | 224 | 11 | 27634302 | |
| Pubmed | SCFD2 ATP7A CAND2 MYO5A USP11 PIEZO1 NDUFB8 ITPR2 STIM1 MDN1 FAM120A SUPT6H PIP5K1A CLUH SYNE1 BAG5 N4BP2 TMEM209 MRPS9 EDRF1 TP53BP1 NIN | 2.67e-04 | 1487 | 224 | 22 | 33957083 | |
| Pubmed | FBXL13 ATP7A CDC42SE1 GCNT1 ITPR2 NF1 MDN1 ADSL EVA1A COG4 ATF7 WRN PHTF2 NOX4 KMO MTOR PDE4DIP MYOM2 PLK4 TP53BP1 | 2.90e-04 | 1293 | 224 | 20 | 15342556 | |
| Pubmed | KMT2B ATP8A2 KDM3B ADAMTS15 PIP5K1A MMP12 RC3H2 DNAH10 USP24 PPM1B POLR3B DNAH17 PLK4 KLHL17 | 3.03e-04 | 730 | 224 | 14 | 34857952 | |
| Pubmed | 3.05e-04 | 197 | 224 | 7 | 36604605 | ||
| Pubmed | 3.14e-04 | 91 | 224 | 5 | 22610502 | ||
| Pubmed | USP34 KDM3B GATAD2B ITPR2 ZCCHC14 FAM120A SMG9 TASOR CLUH COG4 POLR3B N4BP2 TMEM209 CPSF3 | 3.16e-04 | 733 | 224 | 14 | 34672954 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 KMT2B PIEZO1 NAGLU KDM3B EDC4 ITPR2 ZCCHC14 SLC38A10 MDN1 MYRF PUF60 DYRK1A CIT CELSR3 MTOR ANKRD33B KLHL17 | 3.19e-04 | 1105 | 224 | 18 | 35748872 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 3.19e-04 | 262 | 224 | 8 | 36880596 | |
| Pubmed | 3.82e-04 | 146 | 224 | 6 | 21399614 | ||
| Pubmed | 3.97e-04 | 147 | 224 | 6 | 29576527 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.97e-04 | 341 | 224 | 9 | 32971831 | |
| Pubmed | 4.08e-04 | 5 | 224 | 2 | 35764636 | ||
| Pubmed | 4.08e-04 | 5 | 224 | 2 | 25589557 | ||
| Pubmed | 4.08e-04 | 5 | 224 | 2 | 25194337 | ||
| Pubmed | 4.08e-04 | 5 | 224 | 2 | 26565025 | ||
| Pubmed | AROS-29 is involved in adaptive response to oxidative stress. | 4.08e-04 | 5 | 224 | 2 | 16551573 | |
| Pubmed | 4.08e-04 | 5 | 224 | 2 | 33840455 | ||
| Cytoband | 4q28 | 9.42e-06 | 9 | 224 | 3 | 4q28 | |
| GeneFamily | Dyneins, axonemal | 2.68e-04 | 17 | 137 | 3 | 536 | |
| Coexpression | GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP | 5.35e-06 | 193 | 218 | 10 | M7244 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 6.70e-06 | 198 | 218 | 10 | M6511 | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 7.64e-07 | 199 | 223 | 9 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.96e-07 | 200 | 223 | 9 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.96e-07 | 200 | 223 | 9 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | ASK428-Epithelial-Secretory|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.36e-06 | 170 | 223 | 8 | 9e275c4a70f9866f770fbdb0fe14a577287fe290 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 172 | 223 | 8 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 172 | 223 | 8 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.69e-06 | 173 | 223 | 8 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.61e-06 | 180 | 223 | 8 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-06 | 181 | 223 | 8 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-06 | 183 | 223 | 8 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.08e-06 | 183 | 223 | 8 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-06 | 183 | 223 | 8 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-06 | 184 | 223 | 8 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-06 | 187 | 223 | 8 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-leukocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-06 | 188 | 223 | 8 | 61b6047affa18c5e71210fcce449e2bbe7cf141b | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.98e-06 | 188 | 223 | 8 | 797ce39602f0f78081eb44a21da0d9443f7fd9cf | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-06 | 189 | 223 | 8 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-06 | 190 | 223 | 8 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-06 | 192 | 223 | 8 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 6.04e-06 | 193 | 223 | 8 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.76e-06 | 196 | 223 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.76e-06 | 196 | 223 | 8 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.01e-06 | 197 | 223 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.28e-06 | 198 | 223 | 8 | fab3135f03cf23a9f04f0eed543a9dc181f39f5f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.83e-06 | 200 | 223 | 8 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-06 | 200 | 223 | 8 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.83e-06 | 200 | 223 | 8 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.83e-06 | 200 | 223 | 8 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.83e-06 | 200 | 223 | 8 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.83e-06 | 200 | 223 | 8 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.27e-06 | 144 | 223 | 7 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 1.23e-05 | 153 | 223 | 7 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 1.39e-05 | 156 | 223 | 7 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 161 | 223 | 7 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.00e-05 | 165 | 223 | 7 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 168 | 223 | 7 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.25e-05 | 168 | 223 | 7 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.25e-05 | 168 | 223 | 7 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.25e-05 | 168 | 223 | 7 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.25e-05 | 168 | 223 | 7 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.33e-05 | 169 | 223 | 7 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-05 | 169 | 223 | 7 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | Mild-Treg|World / Disease group and Cell class | 2.42e-05 | 170 | 223 | 7 | f3f177534badca34e1ae8671b7f583ee6688e14b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 171 | 223 | 7 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-05 | 173 | 223 | 7 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | Tuft-tuft-4|World / Class top | 2.81e-05 | 174 | 223 | 7 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.81e-05 | 174 | 223 | 7 | 7d2f802f493f19a068e097b2909a9000e2160266 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.92e-05 | 175 | 223 | 7 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 175 | 223 | 7 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.03e-05 | 176 | 223 | 7 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-05 | 177 | 223 | 7 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-05 | 177 | 223 | 7 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 177 | 223 | 7 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 178 | 223 | 7 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 3.37e-05 | 179 | 223 | 7 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.49e-05 | 180 | 223 | 7 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.49e-05 | 180 | 223 | 7 | 255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 3.49e-05 | 180 | 223 | 7 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 3.62e-05 | 181 | 223 | 7 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 181 | 223 | 7 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 3.62e-05 | 181 | 223 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 181 | 223 | 7 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 223 | 7 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 181 | 223 | 7 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 223 | 7 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 223 | 7 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 223 | 7 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.75e-05 | 182 | 223 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 183 | 223 | 7 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 3.88e-05 | 183 | 223 | 7 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 183 | 223 | 7 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 3.88e-05 | 183 | 223 | 7 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-05 | 183 | 223 | 7 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.88e-05 | 183 | 223 | 7 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 184 | 223 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-05 | 184 | 223 | 7 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 184 | 223 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 184 | 223 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.16e-05 | 185 | 223 | 7 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.16e-05 | 185 | 223 | 7 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.16e-05 | 185 | 223 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.16e-05 | 185 | 223 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 185 | 223 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-05 | 185 | 223 | 7 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-05 | 185 | 223 | 7 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-05 | 186 | 223 | 7 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-05 | 186 | 223 | 7 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.45e-05 | 187 | 223 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 187 | 223 | 7 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-05 | 188 | 223 | 7 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-05 | 188 | 223 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-05 | 188 | 223 | 7 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-05 | 188 | 223 | 7 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-05 | 188 | 223 | 7 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.76e-05 | 189 | 223 | 7 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 189 | 223 | 7 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-05 | 190 | 223 | 7 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-05 | 190 | 223 | 7 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-05 | 190 | 223 | 7 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-05 | 190 | 223 | 7 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| Disease | Intellectual Disability | MAP1B ATP8A2 SDCCAG8 NAGLU KDM3B ZMYM2 NF1 ADSL ZBTB40 PUF60 SYNE1 POLR3B MTOR SETBP1 | 5.80e-06 | 447 | 215 | 14 | C3714756 |
| Disease | Malignant neoplasm of breast | CEP85L ITGA9 ZCCHC14 TMEM161A NOP9 NF1 TOX3 TBXAS1 SYNE1 PIGS SH2D3A MANEA SLC39A12 TCL1B MTOR N4BP2 SETBP1 TENM1 CPSF3 TP53BP1 | 1.26e-04 | 1074 | 215 | 20 | C0006142 |
| Disease | protein-tyrosine sulfotransferase 1 measurement | 3.14e-04 | 4 | 215 | 2 | EFO_0801970 | |
| Disease | severe acute respiratory syndrome, COVID-19 | ATP8A2 ADARB2 TENM2 TOX3 WRN KCNAB2 ACSF2 KIAA1217 PDE4DIP AUTS2 TUBD1 | 4.73e-04 | 447 | 215 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | Tourette syndrome | 4.85e-04 | 50 | 215 | 4 | EFO_0004895 | |
| Disease | total blood protein measurement | IQGAP2 NYNRIN CH25H PHTF2 DNAH1 NFATC2IP SLC18A1 CD86 SUSD5 TUBD1 ANKRD33B | 4.91e-04 | 449 | 215 | 11 | EFO_0004536 |
| Disease | alkaline phosphatase measurement | USP34 SLC26A4 NT5DC1 JAK1 NF1 ADSL ATRIP NYNRIN ZBTB40 MYRF CLUH COG4 ATF7 SLC17A1 STKLD1 CNOT1 TP53BP1 KLHL17 | 4.92e-04 | 1015 | 215 | 18 | EFO_0004533 |
| Disease | Profound Mental Retardation | 5.61e-04 | 139 | 215 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.61e-04 | 139 | 215 | 6 | C0025363 | |
| Disease | Mental deficiency | 5.61e-04 | 139 | 215 | 6 | C0917816 | |
| Disease | crescentic glomerulonephritis (implicated_via_orthology) | 7.78e-04 | 6 | 215 | 2 | DOID:13139 (implicated_via_orthology) | |
| Disease | eye disease (implicated_via_orthology) | 7.78e-04 | 6 | 215 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | unipolar depression, schizophrenia | 7.79e-04 | 25 | 215 | 3 | EFO_0003761, MONDO_0005090 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 1.08e-03 | 7 | 215 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 1.08e-03 | 7 | 215 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | Renal dysplasia and retinal aplasia | 1.08e-03 | 7 | 215 | 2 | cv:C0403553 | |
| Disease | cerebral infarction (is_implicated_in) | 1.21e-03 | 29 | 215 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | lung carcinoma, family history of lung cancer | 1.21e-03 | 29 | 215 | 3 | EFO_0001071, EFO_0006953 | |
| Disease | Epileptic encephalopathy | 1.34e-03 | 30 | 215 | 3 | C0543888 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.39e-03 | 291 | 215 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | seasonal gut microbiome measurement | 1.40e-03 | 112 | 215 | 5 | EFO_0007753 | |
| Disease | hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) measurement | 1.44e-03 | 8 | 215 | 2 | EFO_0800583 | |
| Disease | triacylglycerol 58:6 measurement | 1.44e-03 | 8 | 215 | 2 | EFO_0010440 | |
| Disease | fear of minor pain measurement | 1.48e-03 | 31 | 215 | 3 | EFO_0008340 | |
| Disease | QRS duration | 1.62e-03 | 298 | 215 | 8 | EFO_0005055 | |
| Disease | response to aromatase inhibitor | 1.62e-03 | 32 | 215 | 3 | GO_0061477 | |
| Disease | intelligence, self reported educational attainment | 1.70e-03 | 117 | 215 | 5 | EFO_0004337, EFO_0004784 | |
| Disease | mortality | 1.74e-03 | 173 | 215 | 6 | EFO_0004352 | |
| Disease | nephronophthisis (implicated_via_orthology) | 1.84e-03 | 9 | 215 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | underweight body mass index status | 1.84e-03 | 9 | 215 | 2 | EFO_0005936 | |
| Disease | Testicular Germ Cell Tumor | 2.01e-03 | 73 | 215 | 4 | EFO_1000566 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 2.29e-03 | 10 | 215 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | JT interval | 2.37e-03 | 248 | 215 | 7 | EFO_0007885 | |
| Disease | language impairment | 2.78e-03 | 11 | 215 | 2 | EFO_0005425 | |
| Disease | N-acetylphenylalanine measurement | 2.78e-03 | 11 | 215 | 2 | EFO_0800019 | |
| Disease | serum gamma-glutamyl transferase measurement | TP53INP1 IQGAP2 DOCK11 NAGLU ITGA9 TENM2 NF1 EVA1A HACE1 HSD17B13 DYRK1A CIT ZZZ3 STKLD1 TP53BP1 | 3.02e-03 | 914 | 215 | 15 | EFO_0004532 |
| Disease | energy intake | 3.06e-03 | 134 | 215 | 5 | EFO_0003939 | |
| Disease | Epilepsy, Cryptogenic | 3.08e-03 | 82 | 215 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 3.08e-03 | 82 | 215 | 4 | C0751111 | |
| Disease | Aura | 3.08e-03 | 82 | 215 | 4 | C0236018 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.16e-03 | 195 | 215 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | KMT2B SYN3 BCL3 EYA1 SPATA31C1 NT5DC1 NRXN3 NF1 NYNRIN TASOR MYRF DNAH10 PARP10 NFATC2IP SLC17A1 SLC18A1 TP53BP1 | 3.19e-03 | 1106 | 215 | 17 | EFO_0021796 |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 3.32e-03 | 12 | 215 | 2 | C0403553 | |
| Disease | high grade glioma (is_marker_for) | 3.55e-03 | 42 | 215 | 3 | DOID:3070 (is_marker_for) | |
| Disease | Bardet-Biedl Syndrome | 3.91e-03 | 13 | 215 | 2 | C0752166 | |
| Disease | diastolic blood pressure, systolic blood pressure | SCFD2 DCDC1 MAP1B SDCCAG8 ADAMTS15 SMG9 FAM13C SLC39A12 SUGCT N4BP2 SETBP1 CPSF3 | 3.92e-03 | 670 | 215 | 12 | EFO_0006335, EFO_0006336 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 4.27e-03 | 276 | 215 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | total lipids in small LDL | 4.89e-03 | 47 | 215 | 3 | EFO_0022168 | |
| Disease | obesity (implicated_via_orthology) | 5.07e-03 | 215 | 215 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 5.18e-03 | 216 | 215 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 5.21e-03 | 15 | 215 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Situs ambiguus | 5.21e-03 | 15 | 215 | 2 | C0266642 | |
| Disease | glycerate measurement | 5.21e-03 | 15 | 215 | 2 | EFO_0021029 | |
| Disease | Colonic Neoplasms | 5.22e-03 | 152 | 215 | 5 | C0009375 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.22e-03 | 152 | 215 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_marker_for) | 5.49e-03 | 49 | 215 | 3 | DOID:9119 (is_marker_for) | |
| Disease | Colorectal Carcinoma | PCSK2 MAP1B ADARB2 NF1 ADAMTS15 SHANK1 SYNE1 WRN ZZZ3 SETBP1 TENM1 EDRF1 | 5.64e-03 | 702 | 215 | 12 | C0009402 |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.81e-03 | 50 | 215 | 3 | EFO_0022247 | |
| Disease | QRS amplitude, QRS complex | 5.81e-03 | 50 | 215 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 5.91e-03 | 222 | 215 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 5.93e-03 | 16 | 215 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | amygdala volume change measurement | 5.93e-03 | 16 | 215 | 2 | EFO_0021490 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 6.02e-03 | 99 | 215 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | QT interval | 6.06e-03 | 534 | 215 | 10 | EFO_0004682 | |
| Disease | alpha fetoprotein measurement | 6.23e-03 | 100 | 215 | 4 | EFO_0010583 | |
| Disease | Malignant tumor of colon | 6.30e-03 | 159 | 215 | 5 | C0007102 | |
| Disease | creatinine measurement | CAND2 DCDC1 USP11 SDCCAG8 EYA1 ADARB2 TUB ADSL PIP5K1A ATF7 PHTF2 RFWD3 ZZZ3 CELSR3 SETBP1 | 6.52e-03 | 995 | 215 | 15 | EFO_0004518 |
| Disease | calcium measurement | SCFD2 ZMYM2 EYA1 NT5DC1 STIM1 FAM120C NYNRIN PIP5K1A PHTF2 CD86 ATP1A4 | 6.64e-03 | 628 | 215 | 11 | EFO_0004838 |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 6.68e-03 | 102 | 215 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | response to phenylephrine | 6.69e-03 | 17 | 215 | 2 | EFO_0010152 | |
| Disease | Moyamoya Disease | 6.69e-03 | 17 | 215 | 2 | C0026654 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MPSETHAMLATLARV | 1 | Q9HAC7 | |
| GTTLMRAMLDAHPDI | 81 | O60507 | |
| GSAPMQLHLRATIRM | 76 | O95445 | |
| MDMGNQHPSISRLQE | 1 | Q9UL15 | |
| KPRSSLGMHMLESVQ | 621 | A6NCI8 | |
| DRTMIGEPMNFVHLT | 26 | Q9NRR8 | |
| HIMSEPEEITTMSGQ | 366 | Q9UKF6 | |
| DLGSPQLAMHSIREM | 441 | Q9ULA0 | |
| GMLDMLRGDSSHVVS | 101 | Q9NUP1 | |
| GHSRTLQEMEMSLPE | 471 | Q9NPI1 | |
| MMGDHTIKSQRPRSV | 256 | O60242 | |
| SKMNIGMETLPHERL | 1326 | O60242 | |
| MIMSGFSRLLNHAVP | 276 | Q13686 | |
| ESKMVTLHRMGPNLQ | 71 | Q9H9E3 | |
| MGPLTQHSSMTNLVR | 1281 | P51816 | |
| HRTSMVRQAALPIME | 476 | Q969M2 | |
| PMLLHVAAQIASGMR | 741 | Q08345 | |
| MPHSIMRVDIAGRDV | 176 | P42025 | |
| MVFTQAPAEIMGHLR | 1 | Q96PS8 | |
| ESVGRIMPHTEARIM | 431 | Q96CM8 | |
| RTELSMPIQSHVIMT | 461 | P17544 | |
| HLTMRQGADREESPM | 736 | Q13627 | |
| KPTGMIRIHQMNSEL | 116 | P42081 | |
| ITKALLPSMMERNHG | 151 | Q7Z5P4 | |
| LPSMMERNHGHIVTV | 156 | Q7Z5P4 | |
| MSAIVRSPEHQPSAM | 1316 | O14578 | |
| PDMRGQATMVLSSAH | 1056 | Q9NTI2 | |
| STVDMSMPVREHTLL | 1371 | O60312 | |
| ANHMMSPTLIQIDRA | 386 | Q8TE58 | |
| DGGVLDHMVRMTTSL | 301 | A6NCL7 | |
| QHRVLDQMRSFGMTP | 226 | P54802 | |
| HSMVDESLITGEAMP | 866 | Q04656 | |
| IIRSNSLPPMDVMHS | 711 | Q9HBD1 | |
| GHTVMEKLPSGMEIS | 371 | Q9Y5P3 | |
| EHTMSLQPASMISPL | 326 | P29558 | |
| PDKNHTTIRSVLMEM | 656 | Q6PCD5 | |
| ARVMSHRMEGVGQLP | 596 | Q9NS39 | |
| DPITRDHMGSVMAQV | 1351 | Q6P2E9 | |
| MRLPLSHSPEHVEMA | 1 | Q9H8M9 | |
| NVVMRHDIPDLGTMS | 166 | Q96G21 | |
| MIGPTHGQMTVTRLV | 1091 | P23458 | |
| TGQLDTSTLEMMHAP | 76 | P39900 | |
| PGLLEAETMRHIFMN | 1266 | Q14571 | |
| TPRTMHTSVMALDRL | 391 | Q8NAB2 | |
| EMMDLQHGSLFLRTP | 61 | P00338 | |
| SLIITGGSIHPMEME | 251 | Q9H2P9 | |
| TLTQRFPHSEMTTLM | 7061 | Q8WXI7 | |
| FSHSQMSTLMRRGPE | 7941 | Q8WXI7 | |
| HSQMTALMSRTPGDV | 9116 | Q8WXI7 | |
| MTEIMSSNRIHIPDS | 9911 | Q8WXI7 | |
| GSDSPIQTDHMMERL | 516 | M0R2J8 | |
| ISEILNSHGNIMPMD | 276 | Q9H649 | |
| PETGEERDLMVHNIM | 76 | Q86U38 | |
| SMDPVHGDISRAMRN | 2291 | Q9NU22 | |
| RASHGTKMMTPEVLA | 86 | Q5TFE4 | |
| MQVTLIPTHDSEVMR | 2416 | P46821 | |
| TFEDIHMLVGSNMPI | 311 | Q3B7T1 | |
| MLSAHPETSMIRTVN | 351 | Q8NBH2 | |
| HDPDLVEINRSMMSP | 641 | A6NM62 | |
| GMSHSALVPMLKEQR | 661 | Q8N448 | |
| HVAGIAAMMLSAEPE | 391 | Q8NBP7 | |
| MEMQDLTSPHSRLSG | 1 | Q99502 | |
| PMVMADQHRSVSELL | 36 | Q8IYU2 | |
| EDVSQDPGLSHLMMS | 236 | Q9Y4C0 | |
| DPGLSHLMMSEQARE | 241 | Q9Y4C0 | |
| IHPMNSISSLDRTRM | 1031 | Q8WXX7 | |
| VDMPKLHDAMGTRSL | 631 | Q5TB30 | |
| MSGSTPFQMRLVHLD | 1 | Q8WVB3 | |
| SVDPRLIHVMLMDNS | 241 | Q7LBC6 | |
| HPEVQVLLLTMMSTA | 511 | Q9UJY4 | |
| MVGILMRHSEEGETP | 1471 | Q9UMN6 | |
| TEHLLRMEMQPTLTD | 221 | Q96FV0 | |
| CLLSMPTRNHMDITT | 531 | Q9NZB2 | |
| ATNTTLPHMLMSQRV | 251 | Q8WXI9 | |
| VMPLGARTASHMTKD | 21 | O95169 | |
| SQVEPPSSDAMMHAR | 906 | P23471 | |
| LTDHLPVAMRLMVSS | 636 | Q9NY59 | |
| TMETDDHMGGIPARN | 376 | Q99755 | |
| DPNTPMEETVRAMTH | 161 | Q13303 | |
| PSVIETHMRQMRSAS | 166 | Q5SRI9 | |
| IISVMSHPSDVMEIR | 311 | Q9NPH5 | |
| GVMHPRTTFLMVDEE | 5561 | Q96RW7 | |
| TTIMSRHSLEEGLDM | 51 | Q7Z309 | |
| RRMELSMGPIQANHT | 86 | P04062 | |
| PSQSEVMGEPHLMVE | 121 | Q9Y244 | |
| EIHRDSTLDPSLMEM | 296 | P10696 | |
| LMVPLMHEVDTSITG | 761 | Q13797 | |
| MRPPEDSTLTTLHDM | 436 | P52757 | |
| EPTLGMDAMASEHRD | 41 | Q8N878 | |
| VRSNIHMVLCMSPIG | 2706 | Q9P2D7 | |
| LVMAAPLSMEHGTVT | 491 | O75419 | |
| DTTMENIMLRVHPDG | 156 | A8MPY1 | |
| MDETQGPLAMTVHLL | 1 | Q9H5Z6 | |
| SIRMPSHNTVELMVV | 401 | Q8N6C5 | |
| APMNIRRSTHDLVAM | 561 | Q6TDP4 | |
| VSQGIPMRARMIHSL | 76 | O15229 | |
| FQTVVMLEMTPELGH | 181 | P13765 | |
| ENIMASLERSMHPEL | 301 | Q5JSL3 | |
| HPRTGTMMLKSSEVL | 1431 | Q9UFH2 | |
| AIVRPMDIQASHALM | 141 | P30550 | |
| IPSLLSMSTRNHMDI | 581 | Q9NX05 | |
| SMSTRNHMDITIPPL | 586 | Q9NX05 | |
| EQIGLHGSRPLQDMM | 536 | Q86UU0 | |
| ADTQETMMDHPLRTI | 531 | Q02410 | |
| LRTIGPSCLHDSMEM | 196 | Q5SZL2 | |
| GIMHLTINDMPTLTD | 351 | Q8NEE6 | |
| IAHGTPVMRLSMPTQ | 501 | Q15723 | |
| PGMQVEVLADSLHMR | 116 | Q08334 | |
| DFGSMVIHLMLPETR | 171 | Q96EH3 | |
| TMHRQLLAPVEGRMA | 746 | Q8IXH8 | |
| SGMTVLQRLMISDSH | 71 | P40197 | |
| ASLMVHVVLPGMVER | 181 | Q3SXM5 | |
| HQFDQVMPGVSMLIR | 746 | Q8WXE1 | |
| TPNIMLSIDRMEHPS | 2321 | Q9NYQ7 | |
| LMGENNLETERMPSH | 236 | Q02742 | |
| PMEHPLSADIAMATR | 116 | P20749 | |
| AMEEPTQTGSNLHML | 416 | O75155 | |
| ETMLTRHTTMVVGPT | 2101 | Q8IVF4 | |
| VSEMPMERDRGAAHS | 181 | Q15768 | |
| SLPMTHRMQLSETNR | 186 | Q9UQ72 | |
| ASLSVTSTRMHEPQM | 131 | Q92681 | |
| TSTRMHEPQMFLGEK | 136 | Q92681 | |
| LVEMLPEMTHVQTQR | 646 | Q504Y0 | |
| LMHFPSNLVTEMLRV | 261 | Q9HBR0 | |
| SMMRHSLPSIFVAGL | 2641 | Q8TDX9 | |
| DMMNVTLLGCHPLTT | 186 | O95992 | |
| EIRDLEMVPDSMLHS | 291 | Q9H2S9 | |
| EMVPDSMLHSSSERP | 296 | Q9H2S9 | |
| ATGVHMMQVDPATLA | 306 | P0C7A2 | |
| APRMLKSHIGNSEMS | 561 | Q8N4N8 | |
| RMSLQSTDLISHPML | 596 | O15259 | |
| PTSRMMLAVHTEPAA | 571 | Q9P2P1 | |
| AEQVSSMPMGSLEHE | 346 | Q53GL7 | |
| ILMVRSLVVSPHEDM | 1636 | P42345 | |
| VISEHSSLLPQDMMS | 146 | Q96S52 | |
| RSPLTLALRVGDHMM | 136 | Q504T8 | |
| VMDSSMPLIGEHVEE | 366 | O14994 | |
| EISGMIMNRVNSHIP | 481 | Q8N3S3 | |
| VMVQPLLDSRMSHSR | 16 | Q9C004 | |
| MTHSSVLPSQMLDVE | 431 | O60279 | |
| PEMLSEQEHMSISGS | 431 | Q9UHX1 | |
| VMMTAGRCHTLLSPV | 5846 | Q8NF91 | |
| QMDKLPSRHAISEVM | 6906 | Q8NF91 | |
| QTHRDALTMSEDRPM | 251 | Q9NX61 | |
| TGSTMLLRETSLMPH | 1206 | Q8NDG6 | |
| QLMEMQHLRSTATPS | 1956 | Q8N4C6 | |
| HRITPDMSLQNMKGT | 1401 | P0DJD1 | |
| SMPTGNMRASQELHD | 1056 | Q5VVP1 | |
| PLRSLEHEETNMPTM | 101 | Q86SQ7 | |
| SRAMIDSRTPEEMKH | 1341 | Q13576 | |
| MTEFHLQSQMPSIRL | 1 | Q8NGC0 | |
| EGIMQIPRNSHRTTM | 991 | Q7RTY7 | |
| NLTMVVMVNSTDPHG | 41 | Q14916 | |
| SLARHLMTLVMDPLQ | 306 | P30566 | |
| MPTGNMRASQELHDL | 1061 | Q8IWB4 | |
| QVMSMARPQLSHTIL | 476 | Q9H0W8 | |
| PVGTSAIHMSLLEMR | 636 | Q5T5P2 | |
| VVPLSGMMVRHAQSS | 876 | Q5T5P2 | |
| TLMSTEEGRPHFELM | 171 | Q8WTS6 | |
| MQVLHPAARMLVELS | 81 | P50991 | |
| LLSVTMPSMVRHSLQ | 1911 | Q9UKZ4 | |
| LLAVTMPSVARHSMS | 1961 | Q9NT68 | |
| VSQHLIRPLMGMSLA | 131 | Q9H9Q4 | |
| EQVGSMGLVEMLHRS | 46 | Q9Y484 | |
| IAESRILPLMTIGMH | 1276 | Q14191 | |
| GMPDLAHVMRILSAE | 331 | O75688 | |
| PGHTNDVMVNMIALT | 301 | Q8WU76 | |
| LSMSNLHEATMPVLL | 501 | Q8NE31 | |
| DLMSARRSNMGHKEP | 926 | P0DKV0 | |
| RMSEPLQSVVDHMAT | 281 | Q8NCF5 | |
| AVSPREALMEAMHTV | 436 | Q68BL8 | |
| RMVMHSAASPTQAPI | 836 | O00444 | |
| GHAMPRLAVTNTTMT | 161 | Q13586 | |
| IPLGRDMHSLVMRND | 91 | Q5W111 | |
| QMMSPLQIERSLSVH | 181 | Q8WUJ0 | |
| SMMVFRIGIPDLHQT | 71 | Q9Y566 | |
| MVTSDHIVPGDMARE | 1171 | Q9UK61 | |
| SSQTHVLMMKGAPER | 506 | Q13733 | |
| MVTIRSHMLTPFVEE | 186 | O75746 | |
| ISSLSMKAQPERMHV | 31 | Q8NCG5 | |
| AVLMSERVMGTEHPN | 1046 | O75153 | |
| HPTMSVDEVLEMLQR | 861 | A5YKK6 | |
| LESRTQLVTMCHMGP | 1011 | Q7KZ85 | |
| MPTGNMRASQELHDL | 1061 | Q5VYP0 | |
| MATLPESMHSIPLTN | 16 | Q63HM9 | |
| MLSVRNIPHMSENSL | 271 | Q9UJT1 | |
| MVLDARHSASPMGVQ | 281 | P24557 | |
| VVGHTMERSPMHVRN | 561 | Q8IYI8 | |
| MHDSNTGIRSSPNME | 136 | Q9NYT0 | |
| RHLANMMGEDPETFT | 86 | P82933 | |
| LMVGSVVLSMAPDEH | 146 | O43511 | |
| MPTGNMRASQELHDL | 1061 | Q5VU36 | |
| QQPSRSHLMRSGSVM | 521 | Q8WVR3 | |
| VHMAAAGIPSMSTRD | 136 | Q9NXZ1 | |
| ADMPAMSTRDQHATI | 376 | Q9NXZ1 | |
| HRQMVPASITDMLLE | 311 | Q8NE28 | |
| HPHIEVMRIDGTMDS | 1251 | Q15413 | |
| VMGALLMPQVSRLEH | 416 | Q9BRG2 | |
| HPQLSAMIRGQDAEM | 286 | Q9H0U9 | |
| TSPMENLLIEHPSMS | 116 | Q96A56 | |
| RGLMSQPLMETCHSV | 461 | P28908 | |
| SQMSMDHEELLRTPG | 641 | P21359 | |
| ERHSSNSLPGLMMDL | 396 | Q9NRW7 | |
| LALMTHITTDMEDGP | 496 | Q9NW08 | |
| EMSGQDFHLSTREMP | 491 | Q9BWV7 | |
| SIVHMTDAARSGVMP | 156 | O15405 | |
| MSESMVETHDPILGS | 956 | Q12888 | |
| MAVHTRELLSSGQMP | 66 | O95988 | |
| QPGRALVMTRMDSIS | 691 | Q5HYM0 | |
| MMQGEAHPSASLIDR | 1 | Q96SK2 | |
| DGRDMNLMITHVTSL | 206 | Q9UBW7 | |
| QMLSAASHITPIRML | 496 | Q8WYQ9 | |
| TGVTQTPRHLVMGMT | 21 | A0A589 | |
| LRLDTHPAMVTVLEM | 601 | Q12931 | |
| RHLQQGSESPMMIGE | 2596 | Q9UPU5 | |
| MRHLPSQESGIREMH | 56 | Q96JF6 | |
| NMMVLVSRAVEHPSV | 241 | Q9NQZ5 | |
| MQLTDMEHVSLPGTR | 706 | Q92508 | |
| MGPVRMISSGHELTT | 1276 | Q70CQ2 | |
| GMDPITRQVGQHIEM | 516 | Q8IWV8 | |
| MATIEAVIHMAREAP | 1506 | Q9Y6X0 | |
| TGVTQTPRHLVMGMT | 21 | A0A539 | |
| FSMTERLPPIQSMVH | 61 | Q6ZQQ6 | |
| VSAQMMSLSEPQEHR | 361 | Q8IYH5 | |
| AVSMLEADHMLPSRI | 356 | Q99959 | |
| SVIVPGMNMVHERVS | 386 | P50607 | |
| KHTGISPERMMVADV | 531 | P51784 | |
| GNDMLMNTPRAHTVE | 226 | Q9BVW5 | |
| MISHMTSLAPGEREV | 486 | Q9NUA8 | |
| MPIMGHLVDLRHTSV | 411 | P54219 | |
| TLTHLGARMMELTNV | 271 | Q9H3M0 | |
| LQPMIVSGMLEHETI | 1621 | Q9Y4I1 | |
| MRAVTPENHESMTSI | 1206 | Q86UW6 | |
| ISSSEHMRIGGSEEM | 1271 | P54296 | |
| HLLEEPTSMEVQPMT | 201 | Q5VU43 | |
| NVKVMGSLMHPSDLR | 576 | Q9Y2G1 | |
| MTDIIEASSISHMPQ | 246 | P16519 |